Analyst Recommendations

Scotiabank analyst issues SECTOR PERFORM recommendation for BP on October 10, 2024 07:28AM ET. The previous analyst recommendation was Outperform.BP was trading at $31.98 at issue of the...

October 10, 2024   BP -0.31%

Scotiabank analyst issues OUTPERFORM recommendation for OXY on October 10, 2024 07:50AM ET. The previous analyst recommendation was Outperform.OXY was trading at $53.9 at issue of the analyst...

October 10, 2024   OXY 0.16%

Scotiabank analyst issues OUTPERFORM recommendation for CVX on October 10, 2024 07:48AM ET. The previous analyst recommendation was Outperform.CVX was trading at $149.65 at issue of the analyst...

October 10, 2024   CVX -0.89%

Scotiabank analyst issues OUTPERFORM recommendation for DVN on October 10, 2024 07:49AM ET. The previous analyst recommendation was Outperform.DVN was trading at $41.96 at issue of the analyst...

October 10, 2024   DVN 0.21%

Scotiabank analyst issues SECTOR PERFORM recommendation for MRO on October 10, 2024 07:50AM ET. The previous analyst recommendation was Sector Perform.MRO was trading at $28.14 at issue of...

October 10, 2024   DVN 0.21%

Morgan Stanley analyst issues OVERWEIGHT recommendation for NVDA on October 10, 2024 07:05AM ET. The previous analyst recommendation was Overweight.NVDA was trading at $132.65 at issue of the...

October 10, 2024   NVDA -0.34%

Citigroup analyst issues NEUTRAL recommendation for RTX on October 10, 2024 06:05AM ET. The previous analyst recommendation was Neutral.RTX was trading at $123.95 at issue of the analyst...

October 10, 2024   RTX 0.00%

Citigroup analyst issues NEUTRAL recommendation for NFLX on October 10, 2024 06:26AM ET. The previous analyst recommendation was Neutral.NFLX was trading at $727.43 at issue of the analyst...

October 10, 2024   NFLX -5.10%

Morgan Stanley analyst issues OVERWEIGHT recommendation for NFLX on October 10, 2024 06:33AM ET. The previous analyst recommendation was Overweight.NFLX was trading at $727.43 at issue of the...

October 10, 2024   NFLX -5.10%

Barclays analyst issues OVERWEIGHT recommendation for CVS on October 10, 2024 04:44AM ET. The previous analyst recommendation was Equal-Weight.CVS was trading at $65.97 at issue of the analyst...

October 10, 2024   CVS -2.12%